High content screening is adopted for drug discovery and development. Increasing research in search of the novel drug candidate and target identification & validation is expected to propel the adoption of high content screening over the forecast years. Besides this, continuous focus on manufacturing high quality and technologically advanced cell imaging system is expected to accelerate demand over the course of the forecast period.
The increasing demand for cell visualization and quantification using advance technique has been enabling growth in the global high content market. As per a study by Future Market Insights (FMI), driven by rising application in pharmaceutical and biotech companies, the market is poised to reach a valuation of US$ 1.5 Bn by the end of 2021. As per the study, the pharmaceutical and the healthcare sector will account for over 31% of demand registered in the market in 2021.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-426
However, due to COVID 19 outbreak, the research and development activities were hampered immensely. This is expected to have a negative impact on the market. Nonetheless, increasing investments by key manufacturers in the development of advanced cell imaging product is expected to boost the market in the coming years.
Key Takeaways of High Content Screening Market Study
- The high content screening market will rise at register a little below 5% y-o-y growth in 2021, following a brief period of restrictions amid COVID-19
- Presence of a sophisticated healthcare and pharmaceutical infrastructure is enabling the U.S. market account for over 90% of sales in North America
- The U.K. will register an impressive 7.2% y-o-y growth in 2021 driven by increasing focus on research and development activities in the pharmaceutical sector
- Demand registered in Germany and France is expected to rise significantly within Europe
- Favorable government policies will support expansion in Japan, followed by China
Demand for novel technologies for cell analysis and drug discovery is expected to improve the manufacturing speed, throughput, and reliability. This is expected to create growth opportunities for market players, Says the FMI Analyst.
Who is Winning?
The key manufacturers in the high content screening market are involved in several partnerships and collaboration to develop new cell imaging technology. The leading manufacturers are also making their business strategies by making collaborations with international laboratories and research institutes to develop new imaging technologies.
For instance, In December 2019, Leica Microsystems make a collaboration agreement with the European Molecular Biology Laboratory (EMBL) to develop new imaging technologies applicable in life science. With this agreement EMBL and Leica promoting new imaging technologies for cell imaging.
Valuable Insights into High Content Screening Market Study
Future Market Insights offers actionable insights and a unique perspective on the high content screening market in its latest study, presenting historical demand assessment from 2016 – 2020 and projections from 2021–2031 based on product (cell imaging & analysis, consumables, Softwares, services), industry (pharmaceutical & healthcare, biotechnology, educational institutions, independent CRO, government organizations and others), and by application (primary & secondary screening, target identification & validation, toxicity studies, compound profiling and others) in seven key regions.
Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-426
High content screening equipment is increasingly used for primary & secondary screening of drug molecules, target identification & validation, toxicity studies and compound profiling. A growing number of pharmaceutical, biotechnology and educational institutions across the globe creating huge opportunities for manufacturers to develop technological advance high content screening equipment. Manufacturers in the global high content screening market now focusing to introduce new technological advance high content screening systems to enhance their efficacy and reliability.
For instance, in October 2020 CytoSMART Technologies announced to launch a new advance automated live cell imaging system designed for long-term experiments, large laboratory studies, and comparison studies.
Some of the leading manufacturers are expanding their presence in emerging and untapped regions to maintain or gain market share in the global market. Substantial investments in the manufacturing facility expansion of high content screening systems manufacturing are one of the major trends among key players in the global market.
The leading players in the market are looking forward to holding a strong position in the international market by opening up new product manufacturing facilities.
- Cell Imaging & Analysis
- HCS Instruments
- High-End HCS
- Mid End HCS
- Low-End HCS
- Flow Cytometers
- HCS Instruments
- Reagents & Assay Kits
- Other Consumables
- Pharmaceutical & Healthcare
- Educational Institutions
- Independent CRO
- Government Organizations
- Primary & Secondary Screening
- Target Identification & Validation
- Toxicity Studies
- Compound Profiling
- North America
- Latin America
- East Asia
- South Asia
- Middle East and Africa (MEA)
Key Questions Answered in the Report
Which is the most lucrative market for the high content screening?
Which is the top-selling high content screening equipment?
For which application is high content screening primarily used?
Which are some of the leading companies offering High-Content-Screening?
Buy Complete Report @ https://www.futuremarketinsights.com/checkout/426
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org